The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species.

The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species.

Adenovirus vaccine vectors generated from new viral serotypes are routinely screened in pre-clinical laboratory animal models to identify the most immunogenic and efficacious candidates for further evaluation in clinical human and veterinary settings. Here, we show that studies in a laboratory speci...

Полное описание

Библиографические подробности
Главные авторы:	Dicks, M, Guzman, E, Spencer, A, Gilbert, S, Charleston, B, Hill, A, Cottingham, M
Формат:	Journal article
Язык:	English
Опубликовано:	Elsevier 2015

Схожие документы

Uncovering the mechanisms of adenovirus vector immunogenicity
по: Dicks, M, и др.
Опубликовано: (2013)

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
по: Dicks, M, и др.
Опубликовано: (2012)

Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice
по: Dicks, M, и др.
Опубликовано: (2015)

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
по: Matthew D J Dicks, и др.
Опубликовано: (2012-01-01)

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.
по: Warimwe, G, и др.
Опубликовано: (2013)

Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species
по: Dicks, M, и др.
Опубликовано: (2011)

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors.
по: Cottingham, MG, и др.
Опубликовано: (2012)

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors
по: Cottingham, MG, и др.
Опубликовано: (2011)

Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan children, in the context of vaccine vector efficacy.
по: Dudareva, M, и др.
Опубликовано: (2009)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
по: Ewer (nee Russell), K, и др.
Опубликовано: (2017)

Novel adenovirus vaccine vectors
по: Dicks, M
Опубликовано: (2013)

Chimpanzee adenovirus vaccine provides multispecies protection against Rift Valley Fever
по: Warimwe, G, и др.
Опубликовано: (2016)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
по: Katie Ewer, и др.
Опубликовано: (2017-12-01)

Simian adenoviruses as vaccine vectors
по: Morris, S, и др.
Опубликовано: (2016)

Simian adenoviruses as vaccine vectors
по: Morris, S, и др.
Опубликовано: (2016)

Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys
по: Catherine Collignon, и др.
Опубликовано: (2020-11-01)

Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.
по: Green, C, и др.
Опубликовано: (2015)

Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
по: Adam Berg, и др.
Опубликовано: (2021-10-01)

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.
по: Biswas, S, и др.
Опубликовано: (2011)

A monovalent chimpanzee adenovirus Ebola vaccine — preliminary report
по: Rampling, T, и др.
Опубликовано: (2015)

Manufacturing a chimpanzee adenovirus-vectored SARS-CoV-2 vaccine to meet global needs
по: Joe, CCD, и др.
Опубликовано: (2021)

A monovalent chimpanzee adenovirus ebola vaccine boosted with MVA
по: Ewer (nee Russell), K, и др.
Опубликовано: (2016)

T cells induced by recombinant chimpanzee adenovirus alone and in prime-boost regimens decrease chimeric EcoHIV/NDK challenge virus load.
по: Roshorm, Y, и др.
Опубликовано: (2012)

Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults
по: Green, C, и др.
Опубликовано: (2023)

Chimpanzee Adenovirus Antibodies in Humans, Sub-Saharan Africa
по: Zhiquan Xiang, и др.
Опубликовано: (2006-10-01)

Correlates of Protection Against SIVmac251 Infection in Rhesus Macaques Immunized With Chimpanzee-Derived Adenovirus Vectors
по: Steven Tuyishime, и др.
Опубликовано: (2018-05-01)

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity.
по: Reyes-Sandoval, A, и др.
Опубликовано: (2012)

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity
по: Reyes-Sandoval, A, и др.
Опубликовано: (2012)

Immune Thrombocytopenia Induced by the Chimpanzee Adenovirus-Vectored Vaccine against SARS-CoV-2 Infection
по: Po-Wei Liao, и др.
Опубликовано: (2021-12-01)

Assessment of chimpanzee adenovirus serotype 63 neutralizing antibodies prior to evaluation of a candidate malaria vaccine regimen based on viral vectors.
по: Nébié, I, и др.
Опубликовано: (2014)

A lyophilised formulation of chimpanzee adenovirus vector for long-term stability outside the deep-freeze cold chain
по: Frédéric Mathot, и др.
Опубликовано: (2025-01-01)

Both chimpanzee adenovirus-vectored and DNA vaccines induced long-term immunity against Nipah virus infection
по: Mingqing Lu, и др.
Опубликовано: (2023-11-01)

Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
по: Ewer, K, и др.
Опубликовано: (2013)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens
по: Antrobus, R, и др.
Опубликовано: (2014)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens.
по: Antrobus, R, и др.
Опубликовано: (2014)

Lichenoid drug reaction post-COVID vaccination with the modified chimpanzee adenovirus
по: Paola Garcia-Mendoza, и др.
Опубликовано: (2022-01-01)

Cytokine Responses to Adenovirus and Adenovirus Vectors
по: Svetlana Atasheva, и др.
Опубликовано: (2022-04-01)

Seroprevalence of Neutralizing Antibodies against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients
по: Hua Zhao, и др.
Опубликовано: (2018-03-01)

Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A
по: Stylianou, E, и др.
Опубликовано: (2015)

Peak transgene expression after intramuscular immunization of mice with adenovirus 26-based vector vaccines correlates with transgene-specific adaptive immune responses
по: Sonia Marquez-Martinez, и др.
Опубликовано: (2024-01-01)